(Q37781371)

23 August 2017

Therapeutic strategies for the treatment of dyspepsia (English)

1 reference

23 August 2017

3

Peter Malfertheiner

1 reference

23 August 2017

Arne Kandulski

1

1 reference

PubMed ID

20726822

23 August 2017

Marino Venerito

series ordinal

2

1 reference

PubMed ID

20726822

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Pharmacotherapy

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

2517-2525

1 reference

23 August 2017

15

1 reference

Systemic review: the prevalence and clinical course of functional dyspepsia

23 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Treat the patients' main dyspepsia complaint, not the ROME criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Review article: a critical view on impaired accommodation as therapeutic target for functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Regional cerebral blood flow during gastric balloon distention in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The role of somatosensory cortical regions in the processing of painful gastric fundic distension: an update of brain imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The placebo response in functional bowel disorders: perspectives and putative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Placebo responses in patients with gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The placebo effect for gastroenterology: tool or torment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Management issues in dyspepsia: current consensus and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Dyspepsia management in primary care: a decision analysis of competing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Meta-analysis:Helicobacter pylori‘test and treat’ compared with empirical acid suppression for managing dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Long-term tegaserod treatment for dysmotility-like functional dyspepsia: results of two identical 1-year cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Prokinetics and fundic relaxants in upper functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The effects of capsaicin on reflux, gastric emptying and dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Red pepper and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The treatment of functional dyspepsia with red pepper

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Japanese herbal medicine in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Review article: current and emerging therapies for functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A systematic review of psychological therapies for nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Quality indicators for colonoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.501794

Pharmacological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Psychological interventions for non-ulcer dyspepsia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002301.PUB4

Identifiers

DOI

10.1517/14656566.2010.501794

1 reference

23 August 2017

1 reference

PubMed ID

20726822